Singapore Medicine - Breakthrough Development of Cell Therapy Treatment f...(ed with us in ramping up capabilities te...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Singapore Medicine - Breakthrough Development of Cell Therapy Treatment for Cancer
Date:10/29/2008
ed with us in ramping up capabilities, technologies, clinical trials development using adoptive T-cells to fight NPC. Conventional chemotherapy alone for patients with advanced NPC does not provide a cure. This is an alternative new treatment strategy," said Dr Toh.
Dr Toh's team, comprising scientists, clinicians, clinician-scientists, researchers and trained nurses, will build up a bench-to-bedside T-cell therapy facility, which is arguably the only one of its kind in Asia.
"T-cell therapy will provide Singapore with a unique opportunity to distinguish ourselves in the region, if not the world. We have the manpower, regulatory framework, infrastructure, the training and the resources, and we are ready to proceed," says Dr Toh.
About National Cancer Centre
National Cancer Centre (NCC) offers comprehensive cancer treatment with a highly skilled, multi-disciplinary team comprising medical specialists, nurses, counselors and other paramedical professionals to meet the special needs of cancer patients. The Centre uses the latest technologies in cancer treatment to help patients access proven innovative therapies for the best clinical outcomes. PCC's commitment is to provide a comprehensive holistic treatment of cancers in a safe and comfortable environment, where patients are attended to by caring and experienced staff. (www.parkwaycancercentre.com)
About the SingaporeMedicine Initiative
Launched in 2003, SingaporeMedicine is a multi-agency government-industry partnership committed to strengthening Singapore's position as Asia's
| Source: PRWeb Copyright©2008 Vocus, Inc. All rights reserved |
Related biology technology :
1. Codexis Appoints Singapore Laboratories Managing Director
2. BioElectronics Corporation Announces Singapore and Malaysia Sales
3. Codexis Opens Singapore Laboratory
4. Alexza Completes $10 Million Equity Financing with Bio*One Capital to Initiate Commercial Manufacturing in Singapore
5. Edwards Lifesciences Opens New Singapore Heart Valve Facility
6. Singapore to hold international pow-wow
7. Center for Molecular Medicine Only Regional Provider of Test Suggested in FDA Alert on Prescribing Codeine to Nursing Mothers
8. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
9. The 3rd Annual Burrill Personalized Medicine Meeting November 12-13, 2007 in San Francisco
10. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkins Lymphoma
11. Agendia Joins the Personalized Medicine Coalition (PMC)
Post Your Comments:
Related Image:
 Singapore Medicine - Breakthrough Development of Cell Therapy Treatment for Cancer |
Breaking Biology Technology:MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 2MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 3MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 4Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 2Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 3Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 4Oxford BioTherapeutics Appoints Michael Moore as Chairman 2Oxford BioTherapeutics Appoints Michael Moore as Chairman 3Oxford BioTherapeutics Appoints Michael Moore as Chairman 4Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas 2Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas 3
[0] MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products[0] Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics[0] Oxford BioTherapeutics Appoints Michael Moore as Chairman[0] Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas
Other Biology Technology:Will tech transfer save Wisconsin's economy? 2Will tech transfer save Wisconsin's economy? 3Will tech transfer save Wisconsin's economy? 4Will tech transfer save Wisconsin's economy? 5Will tech transfer save Wisconsin's economy? 6Will tech transfer save Wisconsin's economy? 7Will tech transfer save Wisconsin's economy? 8State picks long-time vendor for $189m Medicaid information system 2
Breaking Biology News(10 mins):CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation 2The impact of the diffusion of maize to the Southwestern United States 2ADA releases updated position paper on nutrient supplementation 2American Heart Associations Scientific Sessions Media Alert 61378 1Alternative to Warfarin May Cut Risk of Bleeding 61375 1Alternative to Warfarin May Cut Risk of Bleeding 61375 2Largest gene study of childhood IBD identifies 5 new genes 10724 1Largest gene study of childhood IBD identifies 5 new genes 10724 2
Other Biology News:The Economics of Ecosystems and Biodiversity- TEEB 2The Economics of Ecosystems and Biodiversity- TEEB 3The Economics of Ecosystems and Biodiversity- TEEB 4The Economics of Ecosystems and Biodiversity- TEEB 5Fruit fly helps identify protein critical to eggshell formation that may be pesticide target 2Fruit fly helps identify protein critical to eggshell formation that may be pesticide target 3Fruits, vegetables and teas may protect smokers from lung cancer, UCLA researchers report 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |